- Home
- VCEL vs SENS Comparison
VCEL vs SENS Comparison
Compare VCEL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SENS
- Stock Information
- Founded
- VCEL 1989
- SENS 1996
- Country
- VCEL United States
- SENS United States
- Employees
- VCEL N/A
- SENS N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SENS Industrial Machinery/Components
- Sector
- VCEL Health Care
- SENS Industrials
- Exchange
- VCEL Nasdaq
- SENS Nasdaq
- Market Cap
- VCEL 1.6B
- SENS 360.5M
- IPO Year
- VCEL 1997
- SENS N/A
- Fundamental
- Price
- VCEL $34.56
- SENS $7.25
- Analyst Decision
- VCEL Strong Buy
- SENS Strong Buy
- Analyst Count
- VCEL 6
- SENS 6
- Target Price
- VCEL $58.60
- SENS $28.67
- AVG Volume (30 Days)
- VCEL 571.1K
- SENS 702.8K
- Earning Date
- VCEL 11-06-2025
- SENS 11-05-2025
- Dividend Yield
- VCEL N/A
- SENS N/A
- EPS Growth
- VCEL 2045.40
- SENS N/A
- EPS
- VCEL 0.13
- SENS N/A
- Revenue
- VCEL $249,119,000.00
- SENS $25,466,000.00
- Revenue This Year
- VCEL $18.35
- SENS $62.96
- Revenue Next Year
- VCEL $22.26
- SENS $72.62
- P/E Ratio
- VCEL $258.55
- SENS N/A
- Revenue Growth
- VCEL 16.13
- SENS 5.94
- 52 Week Low
- VCEL $29.24
- SENS $5.00
- 52 Week High
- VCEL $63.00
- SENS $28.00
- Technical
- Relative Strength Index (RSI)
- VCEL 47.93
- SENS 77.74
- Support Level
- VCEL $35.47
- SENS $6.98
- Resistance Level
- VCEL $36.99
- SENS $7.56
- Average True Range (ATR)
- VCEL 1.44
- SENS 0.47
- MACD
- VCEL -0.06
- SENS 0.31
- Stochastic Oscillator
- VCEL 33.62
- SENS 82.22
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.